Life Sciences Market Research Reports & Industry Analysis

Publications found: 511,943
Sort by:

Horizon Pharma PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Horizon Pharma PLC Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Retrophin Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Retrophin Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Supernus Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Supernus Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Adaptimmune Therapeutics Plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Adaptimmune Therapeutics Plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Clearside Biomedical Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Clearside Biomedical Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Organovo Holdings Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Organovo Holdings Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

CytomX Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

CytomX Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Insys Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Insys Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Miragen Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Miragen Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Onconova Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Onconova Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

AcelRx Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AcelRx Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Alder BioPharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alder BioPharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ChemoCentryx Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ChemoCentryx Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Fate Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Fate Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Nabriva Therapeutics AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nabriva Therapeutics AG Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Neos Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neos Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

OncoMed Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

OncoMed Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

TG Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TG Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ADMA Biologics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ADMA Biologics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Altimmune Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Altimmune Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Chimerix Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Chimerix Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

EyeGate Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

EyeGate Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tocagen Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tocagen Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Dermira, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Dermira, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ENDRA Life Sciences Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ENDRA Life Sciences Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Regenxbio Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Regenxbio Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Capricor Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Capricor Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Concert Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Concert Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Novocure Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Novocure Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Syndax Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Syndax Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Aduro Biotech Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aduro Biotech Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bellicum Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bellicum Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

FibroGen Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

FibroGen Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ocular Therapeutix Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ocular Therapeutix Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Editas Medicine Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Editas Medicine Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

PLx Pharma Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PLx Pharma Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Agios Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Agios Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Wave Life Sciences Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wave Life Sciences Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Karyopharm Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Karyopharm Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Phibro Animal Health Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Phibro Animal Health Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ionis Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ionis Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Xenon Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Xenon Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

AnaptysBio Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AnaptysBio Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ANI Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ANI Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ProQR Therapeutics NV Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ProQR Therapeutics NV Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vaxart, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vaxart, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Eagle Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Eagle Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Mediwound Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Mediwound Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ascendis Pharma AS Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ascendis Pharma AS Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Pulmatrix Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pulmatrix Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Filters

Search

Categories

282,300
1,254
130
193
402
67
112
212
39
268
170
192
671
866
1,214
153
34
504
109
299
61
384
2,654
1,548
553
205
69
490
372
241
217
199
160
159
115
114
80
79
62
51
38
12
93
146
896
201
142
184
177
386
284
506
57
186
1,762
64,306
14,910
12,134
1,332
926
740
1,080
2,344
222
52
704
151
1,273
225
1,265
433
337
3,434
2,697
1,799
428
1,542
42,070
345
1,037
1,252
3,983
1,323
6,939
85
72
5,113
254
2,856
490
210
2,255
578
1,120
1,850
4,362
2,373
99
1,567
17,119
185

Publishers

3,720
3,041
2,879
251
95
1
799
698
53
4
101,258
3,799
444
210
78,127
1,866
3,776
35
37
202
75
5,253
3,557
10
946
120
123
238
76,468
3,892
68
8,201
2
2,258
21,664
1,891
79
68
703
106
16,437
1
6,889
30,350
501
5,847
1
3
268
1
1
7
4,898
450
142
1
2,189
1
136
9
1,696
8
29
79
8
75
753
11,499
171
321
1
66
5
214
458
56
32,488
3
4
536
197
3
149
74
802
1,261
218
29
5
44
173
124
558
33
159
348
110
186
1,413
393
4
53
61
20
137
111
2
3,749
18
221
330
392
332
51
48,557
140
43
212
3,035
221
689
1,244
389
205
323
37
1,459
7

Regions

379
312
244
244
238
234
231
213
212
212
210
210
208
198
197
183
155
154
152
149
143
141
140
140
139
139
136
136
131
126
115
115
47
43
18
15
14
13
13
13
11
9
8
6
6
5
5
5
4
3
3
3
3
3
3
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1,771
1,559
1,488
1,488
1,384
1,381
665
578
439
383
354
346
311
310
309
308
306
306
303
300
284
281
281
280
275
272
272
270
268
265
264
264
262
261
256
237
233
230
224
219
213
198
169
168
167
167
159
159
153
132
61
32
31
25
14
2,014
634
286
268
1,928
2
134
131
3,238
641
313
208
464,740
194
301
285
275
265
247
236
1,387
1,055
5,487

Price

—

Date

—

Pages

—

Offers

1
391
7
5